Zum Hauptinhalt springen
ProhibitedBinding ruleGBOriginal is EnglishImport aus amtlicher Quelle geprüft

Dibutyltin di(acetate)

The consolidated GB Cosmetics Regulation lists this record in Annex II.

Regulatorische Entscheidung und vollständige Bedingungen

Status
Prohibited
Rechtsrolle
Binding rule
Regulatorische Zusammenfassung
The consolidated GB Cosmetics Regulation lists this record in Annex II.
Bedingungen und Beschränkungen
A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. Öffnen Sie die zitierte Quelle und wenden Sie die unten genannten marktweiten Anforderungen an.

Stoffidentität

Name in der amtlichen Quelle
Dibutyltin di(acetate)
CAS
1067-33-0
EC
213-928-8
Identitätszuordnung
standalone:official_gb_annex

Marktübergreifende Übersicht zu dieser Identität

Exakte verknüpfte Einträge, die derzeit auf dieser Website vorhanden sind. Ein fehlender Markt bedeutet, dass kein exakter Treffer importiert wurde, nicht dass der Stoff verwendet werden darf.

3 Marktdatensätze
Chemische 2D-Struktur aus PubChem für CAS 1067-33-0
CAS 1067-33-0PubChem CID 16682740

Verifizierte Chemie für CAS 1067-33-0

Dibutyltin diacetate

Dibutyltin diacetate is a clear yellow liquid. (NTP, 1992) — CAMEO Chemicals

IUPAC-Name
[acetyloxy(dibutyl)stannyl] acetate
Summenformel
C12H24O4Sn
Molekulargewicht
351.03 g/mol
Exakte Masse
352.069662 Da
Monoisotopische Masse
352.069662 Da
Topologische polare Oberfläche
52,6 Ų
Molekulare Komplexität
227,0
Formale Ladung
0
Wasserstoffbrücken-Donoren
0
Wasserstoffbrücken-Akzeptoren
4
Drehbare Bindungen
10
Schweratome
17
Kovalente Einheiten
1

An PubChem gemeldete Namen und Synonyme

DiacetoxybutyltinDiacetoxydibutyltinDiacetoxydibutylstannaneStannane, bis(acetyloxy)dibutyl-Di-n-butyltin diacetateBis(acetyloxy)dibutylstannaneT 1 (Catalyst)Stannane, diacetoxydibutyl-
16 weitere gemeldete Namen
Dibutylstannium diacetateFomrez sul-3DiacetoxydibutlyltinDibutyl tin diacetateDibutyltin di(acetate)Dibutyltin acetateTin, dibutyl-, diacetateBA 2726NCI-C02028DibutyldiacetoxystannaneBC9AZH1UZGNSC 8786Acetic acid, 1,1'-(dibutylstannylene) esterNSC-8786Dibutly Tin DiacetateRefChem:586576
Kennungen in externen Datenbanken
Erweiterte Strukturstatistik
Definierte Atom-Stereozentren
0
Nicht definierte Atom-Stereozentren
0
Definierte Bindungs-Stereozentren
0
Nicht definierte Bindungs-Stereozentren
0
3D-Konformere
0
Maschinenlesbare Strukturkennungen
SMILES
CCCC[Sn](CCCC)(OC(=O)C)OC(=O)C
InChI
InChI=1S/2C4H9.2C2H4O2.Sn/c2*1-3-4-2;2*1-2(3)4;/h2*1,3-4H2,2H3;2*1H3,(H,3,4);/q;;;;+2/p-2
InChIKey
JJLKTTCRRLHVGL-UHFFFAOYSA-L

Belege aus weiteren wissenschaftlichen Datenbanken

NIH PubChem PUG-View
Exakter Kennungstreffer16682740

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: Dibutyltin diacetate Quelle: NTP Technical Reports
  • NTP Technical Report: TR-183: Bioassay of Dibutyltin Diacetate for Possible Carcinogenicity (CASRN 1067-33-0) (1979 ) Quelle: NTP Technical Reports
  • Peer Review Date: 10/25/78 Quelle: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence Quelle: NTP Technical Reports
  • Conclusion for Female Rat: Inadequate Experiment Quelle: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence Quelle: NTP Technical Reports
  • Conclusion for Female Mice: No Evidence Quelle: NTP Technical Reports
  • Summary: Under the conditions of this bioassay, there was no conclusive evidence for the carcinogenicity of dibutyltin diacetate in male Fischer 344 rats or B6C3F1 mice of either sex. The loss of tissues taken from high dose female rats in this bioassay precluded an evaluation of the carcinogenicity of dibutyltin diacetate to female Fischer 344 rats. Quelle: NTP Technical Reports
  • Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Quelle: Toxin and Toxin Target Database (T3DB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. IMMEDIATELY call a hospital or poison control center even if no symptoms (such as redness or irritation) develop. IMMEDIATELY transport the victim to a hospital for treatment after washing the affected areas.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknow Quelle: CAMEO Chemicals
  • Signal: Danger Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360FD: May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 1.5% (10 of 665) of reports. Quelle: European Chemicals Agency (ECHA)
  • Signal: Danger Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H314 (94.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (82%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H318 (76.5%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H341 (82.4%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360 (64.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H360FD (18.2%): May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H370 (82%): Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372 (92.3%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H400 (58.6%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410 (89%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P260, P261, P264, P264+P265, P270, P272, P273, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P308+P316, P316, P317, P318, P319, P321, P333+P317, P362+P364, P363, P391, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 665 reports by companies from 44 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 10 of 665 reports by companies.; There are 43 notifications provided by 655 of 665 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • Signal: Danger Quelle: NITE-CMC
  • GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]; H400: Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410: Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] Quelle: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P264, P270, P273, P280, P301+P316, P318, P319, P321, P330, P391, P405, and P501 (click each P-code to see the statement) Quelle: NITE-CMC
  • Signal: Danger Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Health Effects: Breathing or swallowing, or skin contact with organotins, can interfere with the way the brain and nervous system work, causing death in severe cases. Organic tin compounds may also damage the immune and reproductive system. (L307, L308) Quelle: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Organotin compounds produce neurotoxic and immunotoxic effects. Organotins may directly activate glial cells contributing to neuronal cell degeneration by local release of pro-inflammatory cytokines, tumor necrosis factor-_, and/or interleukins. They may also induce apoptosis by direct action on neuronal cells. Organotin compounds stimulate the neuronal release of and/or decrease of neuronal cell uptake of neurotransmitters in brain tissue, including aspartate, GABA, glutamate, norepinephrine, and serotonin. This may be either a contributing factor to or result of the neuronal cell loss. The immunotoxic effects of organotins are characterized by thymic atrophy caused by the suppression of proliferation of immature thymocytes and apoptosis of mature thymocytes. Organotin compounds are believed to exert these effects by suppressing DNA and protein synthesis, inducing the expression of genes involved in apoptosis (such as nur77), and disrupting the regulation of intracellular calcium levels, giving rise to the uncontrolled production of reactive oxygen species, release of cytochrome c to the cytosol, and the proteolytic and nucleolytic cascade of apoptosis. The suppression of prolifer Quelle: Toxin and Toxin Target Database (T3DB)

Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen

Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.

Weitere Quellenabdeckung und Trefferstatus
QuelleErgebnisGeprüft
EMBL-EBI ChEBIKein exakter Eintrag2026-08-31
NIH PubChem PUG-ViewExakter Treffer2026-08-31

Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.

Am 2026-09-02 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Amtliche Quelle und Herkunft

Registrierte Quelle
Great Britain Cosmetics Regulation — consolidated Annexes II–VI and amendments
Quellenverweis
GB Cosmetics Regulation, Annex II, entry 1708
Eintrags-ID der Quelle
II-1708
Quellenversion
2026-08-15
Quellsprache
English
Übersetzungsstatus
Original is English
Datum des Inkrafttretens
2026-08-15
Quelle aktualisiert
2026-08-19
Stand geprüft
2026-08-30 04:51 UTC
Validierungsmethode
legislation.gov.uk XML table parse; {'II': 1758, 'III': 326, 'IV': 154, 'V': 57, 'VI': 34}
SHA-256
e3a386d950f54c6e7a7f9e784d1bd46e52de725137e89d5630709824475215d8

Hinweise zum registrierten Datensatz

Datensatzabdeckung
Complete consolidated GB Annexes II–VI, with later amendments versioned separately
Hinweis zur Behörde
Binding GB schedules and versioned amendments to retained Regulation 1223/2009; applies to England, Wales and Scotland, not Northern Ireland
Quellenlizenz
Open Government Licence v3.0 / Crown copyright
Namensnennung
Contains public sector information licensed under the Open Government Licence v3.0.

Wie dieser Eintrag in den Marktdatensatz passt

2329
aktuelle Einträge für Great Britain
1758
Einträge mit dem Status Prohibited
2329
Einträge aus dieser Quellenversion
2015
Markteinträge mit CAS-Identität

Statusverteilung

Bedingungstext ist bei 517 von 2329 aktuellen Einträgen vorhanden. Ein leeres Bedingungsfeld wird entsprechend der oben genannten Eintragsart interpretiert; es wird niemals in die Aussage einer uneingeschränkten Verwendung umgedeutet.

Great Britain Marktkontext

Complete consolidated annex dataset

Abdeckungsversion: GB retained Regulation 1223/2009 schedules, effective 15 August 2026

Current consolidated Annexes II–VI for England, Scotland and Wales.

Verifizierungs-Checkliste

  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.

Amtliche Marktquellen

Verifizierungsablauf und Vollständigkeit des Eintrags

Bevor Sie dieses Ergebnis für eine Compliance-Entscheidung verwenden

  1. Bestätigen Sie, dass „Dibutyltin di(acetate)“ und jede CAS-/EC-Kennung sich auf das Material in Ihrer Lieferantenspezifikation beziehen.
  2. Confirm INCI/CAS/EC identity.
  3. Review every current GB Annex II–VI match.
  4. Check commencement dates and later statutory instruments.
  5. Verify SCPN, responsible-person, safety-report and labelling duties.
  6. Dokumentieren Sie die Quellenversion und prüfen Sie die Behörde vor Herstellung, Notifizierung oder Inverkehrbringen erneut.

In diesem Eintrag verfügbare Felder

  • Amtlicher StoffnameVerfügbar
  • CASVerfügbar
  • ECVerfügbar
  • Gesonderter BedingungstextIn der Quellzeile nicht vorhanden
  • Datum des InkrafttretensVerfügbar
  • Snapshot-Hash und MethodeVerfügbar

Fragen, die diese Seite beantwortet

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

Der Eintrag zitiert GB Cosmetics Regulation, Annex II, entry 1708, Quellenversion 2026-08-15. Die amtliche Quelle öffnen.

Nein. CAS hilft bei der Klärung der Identität, aber Rechtsordnungen können denselben Stoff unterschiedlich einstufen und unterschiedliche Produktbereiche, Grenzwerte, Warnhinweise und Übergangsfristen anwenden.

Dauerhafte Zitierweise

Dibutyltin di(acetate). GB Cosmetics Regulation, Annex II, entry 1708. Great Britain. Source version 2026-08-15. CosIng Checker regulatory record: https://cosingchecker.com/de/regulations/gb/records/6063/

Zitieren Sie die Aufsichtsbehörde als rechtliche Autorität. Diese Seite ist ein strukturierter Belegindex und eine Verifizierungshilfe, kein Ersatz für den amtlichen Text oder eine fachkundige rechtliche Bewertung.

Auslegung und Grenzen für Great Britain

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

Wie die Rechtsrolle auszulegen ist

The cited row forms part of a binding rule or legally incorporated list for this market.

Belege auf dieser Seite

  • Erfasstes Ergebnis: Prohibited
  • Rechtsrolle: Binding rule
  • Quellenversion: 2026-08-15
  • Datum des Inkrafttretens: 2026-08-15

Was es nicht beweist

No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

Weitere maßgebliche Stoffrecherche

Keine dieser Quellen hebt die oben genannte Marktentscheidung auf.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

Diese Identität bei der Quelle recherchieren

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

Diese Identität bei der Quelle recherchieren

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

Diese Identität bei der Quelle recherchieren

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

Diese Identität bei der Quelle recherchieren

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

Diese Identität bei der Quelle recherchieren

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

Diese Identität bei der Quelle recherchieren

US EPA CompTox CTX APIs

Für den Import ist ein API-Schlüssel erforderlich

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

Diese Identität bei der Quelle recherchieren